Mihulka*, s.r.o. was founded in 2016 by Luboš Markovič.
The company is housed in a fully renovated building in the industrial zone Opava-Jaktař located in the North-East part of the Czech Republic. The building features brand new analytical, organic synthesis and biotechnological laboratories, as well as a pilot plant and a manufacturing facility.
The company offers custom synthesis of small molecules for pharmaceutical industry, including cGMP synthesis of active pharmaceutical ingredients (APIs), intermediates and raw materials. Output quantities range from few grams discovery/non-GMP laboratory scale batches to 100 kg batches manufactured under cGMP process controls for late-stage clinical studies and marketed products. In summary, Mihulka offers a full-service custom synthesis development, process scale-up, and technology transfer from laboratory to pilot and commercial production scales.
*Mihulka – named after a tower in Prague Castle, which was used as an alchemy laboratory in the late 16th century, the first one in Europe, for Rudolf II, Holy Roman Emperor.
We strive to be recognized as a preferred contract manufacturing organization (CMO) specializing in the development of value-added novel and innovative syntheses for generic APIs and intermediates and subsequent technology transfers to our cGMP facility.
This goal is achieved by